Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Specialty segment outperforms with improved EBITDA conversion, while management raises guidance on cost efficiency and commercial momentum.
Brenntag (ETR:BNR) executives said demand remained broadly stable in the second quarter and into the start of the third quarter, while the chemicals distributor continued to benefit from a higher pricing environment and progress in commercial and cost-efficiency initiatives. During the company’s se
Soft earnings didn't appear to concern Brenntag SE's ( ETR:BNR ) shareholders over the last week. We think that the...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.